Liquidation Process in Thailand
Liquidation is the process of extracting a company’s assets and using the liquidated assets to pay off any remaining debts. A dissolved company is required to conduct a formal liquidation process according to the Thai Civil and Commercial Code (“CCC”). For a bankrupt company, the liquidation shall be done in accordance with the provisions of …
Wind Energy Landscape in Malaysia
INTRODUCTION In recent years, the Malaysian Government has attempted to enhance the utilisation of renewable energy (“RE”) which aims to conserve the non-renewable sources from being depleted and to ensure the sustainability of energy supply. RE is included in the Fifth Fuel Policy which was implemented under the 8th and 9th Malaysia Plan as the …
A Summary Malaysian Tax & Economic Reliefs
Introduction The sudden and deadly COVID-19 pandemic has led to lockdowns across the globe in an effort to stymy the spread of the virus. The unfortunate side effect of this necessary life-saving measure is a near standstill of business activity within affected countries. This article will look at Malaysian tax relief efforts and consider what …
Continue reading “A Summary Malaysian Tax & Economic Reliefs”
COVID-19: The Malaysian Government’s Additional Stimulus Package
Shortly after the announcement of the PRIHATIN stimulus package worth RM250 billion, the Government announced today that additional measures will be taken to help Malaysian Small and Medium Enterprises (‘SMEs‘) cope with the economic effects of the COVID-19 pandemic and Movement Control Order (‘MCO‘). The additional measures are as follows: –
COVID-19: Recession is Inevitable. Let Us, Lawyers, Be Your Iron Man. Let’s Rescue Your Company!
On 10 April 2020, the Government of Malaysia decided to extend the Movement Control Order (“MCO“) by another 14-days to 28 April 2020. This is the second extension to the MCO, which was originally imposed for a two-week period from 18 March 2020 to 31 March 2020, and was extended to 14 April 2020.1
Video Conferencing: Data Protection Risks for Companies
Introduction In light of the coronavirus pandemic, millions of people around the globe had been forced to work from home. The use of video conferencing tools such as Zoom and Skype has increased significantly as both businesses and individuals relied on the platform to conduct meetings. In the past few months, the daily users of …
Continue reading “Video Conferencing: Data Protection Risks for Companies”
Employee’s Sensitive Personal Data Collection Amid COVID-19
Introduction As the world struggles to combat the COVID-19 (Coronavirus) pandemic, employers around the globe are allowed to collect personal data of employees such as their travel history to prevent the spread of the virus at the workplace. In Malaysia, the Ministry of Human Resources has issued a Frequently Asked Questions (FAQ’S) on Movement Control1 on …
Continue reading “Employee’s Sensitive Personal Data Collection Amid COVID-19”
Amendments in Communiqué on Principles Regarding Real Estate Investment Companies
Capital Markets Board of Turkey (“CMB“) has published the Communiqué Amending the Principles Regarding Real Estate Investment Companies (“Amendment Communiqué“) the Official Gazette dated 9 October 2020 and entered into force on the same date. Changes introduced by the Amendment Communiqué can be summarized as follows:
Turkish Constitutional Court Annulled Article 81/13 of Law on Intellectual and Artistic Works
Pursuant to Law numbered 5846 on Intellectual and Artistic Works (“Law“) reproduced copies of musical and cinematographic works and non-periodical publications should bear a special label, called a banderol for commercial exploitation. The breach of banderole liability crimes and related punishments are regulated under article 81 of the Law. Article 81/13 of the Law, on …
Guideline on Non-clinical Evaluation of Vaccines for Human Use has been Published
On 6 October 2020, Turkish Medicines and Medical Devices Agency (“Agency”) has published “Guideline on Non-clinical Evaluation of Vaccines for Human Use” (“Guideline”). The Guideline aims to provide guidance on “non-clinical evaluation” of vaccine candidates for vaccine developers.